Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | RGP1 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Rgp1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RGP1 mRNA | CTD | PMID:36331819 | RGP1 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Rgp1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RGP1 mRNA | CTD | PMID:22206623 | RGP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rgp1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RGP1 mRNA | CTD | PMID:22298810 | RGP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Rgp1 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RGP1 mRNA | CTD | PMID:25975270 | RGP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rgp1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RGP1 mRNA | CTD | PMID:21570461 | RGP1 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Rgp1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of RGP1 mRNA | CTD | PMID:26251327 | RGP1 | Human | 4,4'-sulfonyldiphenol | increases methylation | ISO | Rgp1 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of RGP1 exon | CTD | PMID:33297965 | RGP1 | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Rgp1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RGP1 mRNA | CTD | PMID:36041667 | RGP1 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Rgp1 (Mus musculus) | 6480464 | bisphenol S affects the methylation of RGP1 gene | CTD | PMID:31683443 | RGP1 | Human | aflatoxin B1 | increases expression | ISO | Rgp1 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of RGP1 mRNA | CTD | PMID:19770486 | RGP1 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of RGP1 gene | CTD | PMID:27153756 | RGP1 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of RGP1 mRNA | CTD | PMID:23724009 | RGP1 | Human | amphetamine | decreases expression | ISO | Rgp1 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of RGP1 mRNA | CTD | PMID:30779732 | RGP1 | Human | bisphenol A | multiple interactions | ISO | Rgp1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RGP1 mRNA | CTD | PMID:36041667 | RGP1 | Human | bisphenol F | multiple interactions | ISO | Rgp1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RGP1 mRNA | CTD | PMID:36041667 | RGP1 | Human | carmustine | affects response to substance | EXP | | 6480464 | RGP1 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 | RGP1 | Human | chlordecone | decreases expression | ISO | Rgp1 (Mus musculus) | 6480464 | Chlordecone results in decreased expression of RGP1 mRNA | CTD | PMID:29980752 | RGP1 | Human | clofibrate | decreases expression | ISO | Rgp1 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of RGP1 mRNA | CTD | PMID:23811191 | RGP1 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of RGP1 mRNA | CTD | PMID:28302478 | RGP1 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of RGP1 mRNA | CTD | PMID:29803840 | RGP1 | Human | epoxiconazole | decreases expression | ISO | Rgp1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of RGP1 mRNA | CTD | PMID:35436446 | RGP1 | Human | finasteride | increases expression | ISO | Rgp1 (Rattus norvegicus) | 6480464 | Finasteride results in increased expression of RGP1 mRNA | CTD | PMID:24136188 | RGP1 | Human | folic acid | multiple interactions | ISO | Rgp1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RGP1 mRNA | CTD | PMID:22206623 | RGP1 | Human | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | decreases expression | EXP | | 6480464 | N more ... | CTD | PMID:12756304 | RGP1 | Human | ozone | multiple interactions | ISO | Rgp1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RGP1 mRNA | CTD | PMID:34911549 | RGP1 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RGP1 mRNA | CTD | PMID:26690555 | RGP1 | Human | perfluorohexanesulfonic acid | decreases expression | ISO | Rgp1 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of RGP1 mRNA | CTD | PMID:37995155 | RGP1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Rgp1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RGP1 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of RGP1 mRNA | CTD | PMID:36331819 | RGP1 | Human | potassium dichromate | decreases expression | ISO | Rgp1 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of RGP1 mRNA | CTD | PMID:23608068 | RGP1 | Human | rotenone | increases expression | ISO | Rgp1 (Rattus norvegicus) | 6480464 | Rotenone results in increased expression of RGP1 mRNA | CTD | PMID:19013527 | RGP1 | Human | sodium dichromate | increases expression | ISO | Rgp1 (Mus musculus) | 6480464 | sodium bichromate results in increased expression of RGP1 mRNA | CTD | PMID:22155349 | RGP1 | Human | sulindac | increases expression | ISO | Rgp1 (Rattus norvegicus) | 6480464 | Sulindac results in increased expression of RGP1 mRNA | CTD | PMID:24136188 | RGP1 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of RGP1 mRNA | CTD | PMID:31533062 | RGP1 | Human | temozolomide | affects response to substance | EXP | | 6480464 | RGP1 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 | RGP1 | Human | tremolite asbestos | increases expression | ISO | Rgp1 (Mus musculus) | 6480464 | tremolite results in increased expression of RGP1 mRNA | CTD | PMID:29279043 | RGP1 | Human | tungsten | decreases expression | ISO | Rgp1 (Mus musculus) | 6480464 | Tungsten results in decreased expression of RGP1 mRNA | CTD | PMID:30912803 | RGP1 | Human | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of RGP1 gene | CTD | PMID:29154799 | RGP1 | Human | valproic acid | affects expression | ISO | Rgp1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of RGP1 mRNA | CTD | PMID:17292431 | RGP1 | Human | zinc sulfate | increases expression | EXP | | 6480464 | Zinc Sulfate results in increased expression of RGP1 mRNA | CTD | PMID:12756304 | |